Effect of Esmolol on Pain Due to Rocuronium

• Status: Completed
• Trial end date: 2013-05-01
• Target enrollment: 0
• Participant gender: All

Summary

90 American society of anesthesiology (ASA) physical status I and II patients undergoing general anesthesia for elective surgery will be included in the study. Patients will be randomized into three groups. Group E will receive esmolol (1 mg/kg), Group IL lidocaine (0.5 mg/kg)and Group C placebo(NaCl 0.9%, 5 mL), followed by a 0.05 mg/kg rocuronium. After intravenous induction with propofol, adequate muscle relaxation for intubation will be received by 0.5 mg/kg rocuronium.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Ankara Diskapi Training and Research Hospital; Etlik Zubeyde Hanim Womens' Health and Teaching Hospital
• Treatments: Esmolol; Lidocaine; Rocuronium

Criteria

Inclusion Criteria:

• ASA physical status I and II patients

• Undergoing general anesthesia for elective surgery

Exclusion Criteria:

• Known allergy to esmolol or lidocaine

• Chronic pain

• Pregnancy

• Withdrawal of consent by the patient